Mucosal Immunology: The Body's First Line of Defense

Added:

The Primacy of Systemic Immunity and the Challenges of Mucosal Tolerance

While mucosal immunity is theoretically the optimal first line of defense, many immunologists emphasize that systemic immunity, primarily mediated by IgG antibodies in the bloodstream, remains the most practical and proven standard for vaccine efficacy. A major criticism of prioritizing mucosal-targeted vaccines is the body's natural bias toward immunological tolerance. The mucosal immune system is designed to tolerate a constant barrage of harmless foreign particles; overcoming this default tolerance to trigger a strong, protective response without causing harmful tissue inflammation is extremely difficult. Additionally, mucosal antibody responses (secretory IgA) are notoriously short-lived compared to the long-lasting systemic memory cells generated by traditional intramuscular vaccines. Furthermore, delivering vaccines via mucosal routes, such as intranasally, presents significant safety hurdles, including the risk of vaccine components accessing the central nervous system via the olfactory nerve. Consequently, some experts argue that focusing on systemic immunity remains a safer, more reliable, and more durable strategy for preventing severe disease and mortality.

Basic components of the immune system, specifically the distinction between innate and adaptive immunity.
The structure and function of antibodies (immunoglobulins), particularly Immunoglobulin A (IgA) and Immunoglobulin G (IgG).
Anatomy of the body's primary barrier surfaces, such as the respiratory, gastrointestinal, and urogenital tracts.
General mechanisms of vaccination, including how antigens trigger immune memory and antibody production.
Design and delivery challenges of mucosal vaccines (e.g., intranasal or oral vaccines) compared to traditional intramuscular injections.
The role of the mucosal microbiome in training the immune system and maintaining epithelial barrier integrity.
Cellular homing mechanisms, including how mucosal lymphocytes traffic to specific mucosal tissues via integrins and chemokines.
Pathogenesis of mucosal-targeting pathogens (like SARS-CoV-2, influenza, or cholera) and how they evade first-line immune defenses.
138.7K views5.2Klikes4:06@CampbellteachingOriginal Release: 2023-04-05

The lungs have a critical function in gas exchange and cannot maintain their own immune factories. Instead, they borrow immunity from off-site factories through a clever mechanism: lung secretions containing antigens are swallowed into the gut, where they reach Peyer's patches and stimulate immune responses. TH17 cells, a subcategory of CD4 helper T cells, migrate from Peyer's patches to the bronchus. These cells are sensitized to specific antigens and then migrate to lung lymphoid tissue. They stimulate B cells to produce IgA antibodies and recruit neutrophils, creating a powerful protective system. This represents a form of 'learned innate immunity' where the innate system becomes more proactive after initial T cell stimulation.